For instance, in marginal zone lymphoma (MZL), AML, B-cell chronic lymphocytic leukemia, or multiple myeloma (MM), CXCR4 expression may have prognostic value (36–39). The gene discussed is CXCR4; the disease is plasma cell myeloma.